T-group (topology)
7575.1.1 Caspase-like
Ligands and drugs
1,764
Member domains
410
with ligand contacts (≤ 4 Å)
23.2% of members
366
with DrugDomain annotations
20.7% of members
192
with a DrugBank compound
10.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7575.1.1 belongs to X-group 7575 Caspase-like, which binds 7.0 ligand superclasses per 20 proteins, narrower than 60% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 49 |
| DB14981 | IHP | Phytic acid | 14 |
| DB04447 | DTT | 1,4-Dithiothreitol | 12 |
| DB01822 | DTD | (4R,5R)-1,2-dithiane-4,5-diol | 3 |
| DB05408 | — | — | 3 |
| DB06255 | — | — | 3 |
| DB00172 | PRO | Proline | 2 |
| DB00282 | — | Pamidronic acid | 2 |
| DB00945 | — | Acetylsalicylic acid | 2 |
| DB01017 | — | Minocycline | 2 |
| DB03124 | 161 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | 2 |
| DB03384 | FXN | Fica | 2 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 2 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 2 |
| DB07696 | DZE | methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate | 2 |
| DB08251 | NA4 | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID | 2 |
| DB08497 | RXB | (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate | 2 |
| DB08498 | RXC | (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate | 2 |
| DB08499 | RXD | N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide | 2 |
| DB12843 | — | — | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 52 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 46 |
| CL | CHLORIDE ION | 41 |
| AZI | AZIDE ION | 35 |
| CAmetal | CALCIUM ION | 19 |
| IHP | INOSITOL HEXAKISPHOSPHATE | 19 |
| ZNmetal | ZINC ION | 16 |
| WSN | N-[(2R)-4-amino-1-imino-4-oxobutan-2-yl]-1-(1-{4-[(2,4-difluorophenyl)methoxy]phenyl}cyclopropane-1-carbonyl)-L-prolinamide | 14 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 12 |
| MRD | (4R)-2-METHYLPENTANE-2,4-DIOL | 10 |
| MGmetal | MAGNESIUM ION | 8 |
| UCI | (3R,5S)-1-(ethanesulfonyl)-5-phenyl-N-[4-(trifluoromethoxy)phenyl]piperidine-3-carboxamide (bound form) | 8 |
| US9 | (3R)-1-(ethanesulfonyl)-N-[4-(trifluoromethoxy)phenyl]piperidine-3-carboxamide | 8 |
| 2GQ | 3-(pyrrolidin-1-yl)isoquinolin-1(2H)-one | 6 |
| DTD | DITHIANE DIOL | 5 |
| A1AAB | N-{7-[(1S)-1-methoxyethyl]-2-methyl[1,3]thiazolo[5,4-b]pyridin-6-yl}-N'-[6-(2H-1,2,3-triazol-2-yl)-5-(trifluoromethyl)pyridin-3-yl]urea | 4 |
| AZ0 | ethyl (5S,8S,14S)-14-hydroxy-5,8,11-tris(2-methylpropyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadecan-15-oate | 4 |
| BAmetal | BARIUM ION | 4 |
| WS9 | N-[(1E,3R)-5-amino-1-(1,3-oxazol-2-yl)-5-oxopent-1-en-3-yl]-1-{1-[4-(trifluoromethoxy)phenyl]cyclopropane-1-carbonyl}-L-prolinamide | 4 |
| 158 | 3-(2-MERCAPTO-ACETYLAMINO)-4-OXO-PENTANOIC ACID | 3 |